Entasis Therapeutics Announces Oral and Poster Presentations of its Pathogen-Targeted Antibiotic Clinical Programs at ASM Microbe 2019
Entasis Therapeutics Holdings Inc. (ETTX)
Last entasis therapeutics holdings inc. earnings: 11/14 07:30 am
Check Earnings Report
Company Research
Source: GlobeNewswire
WALTHAM, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the acceptance of multiple oral and poster presentations on its three clinical programs – ETX2514SUL, zoliflodacin and ETX0282CPDP – at the American Society for Microbiology (ASM) Microbe Conference, being held June 20-24, 2019 in San Francisco, CA. Manos Perros, Chief Executive Officer of Entasis Therapeutics, commented, “We look forward to presenting new findings that support the continued development of each of our three clinical programs. Results from these studies inform our larger clinical initiatives, including the ongoing global ATTACK Phase 3 pivotal trial of ETX2514SUL as a potential treatment for infections caused by carbapenem-resistant Acinetobacter baumannii and the upcoming initiation of a Phase 3 study for zoliflodacin for uncomplicated
Show less
Read more
Impact Snapshot
Event Time:
ETTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETTX alerts
High impacting Entasis Therapeutics Holdings Inc. news events
Weekly update
A roundup of the hottest topics